Clinical TrialsSearch results
Number of results: 272
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Efficacy and Safety Evaluation Study of Implants with Periodontal Ligament
- caries, tooth fracture, luxation of tooth
- Shohei Kasugai
- 2025-01-27
Recruiting
- Study using the App for premenstrual syndrome (PMS) or premenstrual dysphoric mood disorder (PMDD)
- Premenstrual syndrome (PMS) or Premenstrual dysphoric mood disorder (PMDD)
- Ogawa Mariko
- 2025-01-27
Not yet recruiting
- Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
- B-precursor Acute Lymphoblastic Leukemia
- Oda Kazunori
- 2024-12-11
Recruiting
- The effictiveness of QLBi as postoperative analgesia after lumbar operation.
- Patients undergoing lumbar fusion surgery
- Yoshida Keisuke
- 2024-09-25
Recruiting
- Impact of Online Support of Physical Activity Management Using a Wearable Device on Renal Function in Patients with Acute Coronary Syndrome
- Acute coronary syndrome
- Sato Toshimi
- 2024-07-05
Recruiting
- Roll-over study for patients who have completed a prior Novartis-sponsored sabatolimab (MBG453) study and are judged by the investigator to benefit from continued treatment with sabatolimab.
- Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
- Yamauchi Kyosuke
- 2024-06-27
Not yet recruiting
- A follow-up study to test long-term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 1015550
- pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)
- Igarashi Haruki
- 2024-06-07
Recruiting
- Efficacy and safety studies of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
- Multiple sclerosis
- Tanaka Tomoyuki
- 2024-04-12
Recruiting
- Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis
- Multiple sclerosis
- Tanaka Tomoyuki
- 2024-04-12
Recruiting
- Propofol target controlled infusion with the use of liver retractor
- Not specified
- Obara Shinju
- 2024-03-29